ロード中...
Current Role of Autologous and Allogeneic Stem Cell Transplantation for Relapsed and Refractory Hodgkin Lymphoma
Classical Hodgkin lymphoma (cHL) is a relatively rare disease, with approximately 9,200 estimated new cases and 1,200 estimated deaths per year in the United States. First-line chemo-radiotherapy leads to cure rates approaching 80% in patients with advanced-stage disease. However, 25 to 30% of these...
保存先:
| 出版年: | Mediterr J Hematol Infect Dis |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Università Cattolica del Sacro Cuore
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4344175/ https://ncbi.nlm.nih.gov/pubmed/25745542 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4084/MJHID.2015.015 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|